Prevention and control measures significantly curbed the SARS-CoV-2 and influenza epidemics in China

Prevention and control measures significantly curbed the SARS-CoV-2 and influenza epidemics in China

At the end of 2019, an outbreak of pneumonia took place caused by a new coronavirus (SARS-CoV-2 virus), named coronavirus disease 2019 (COVID-19). A series of strict prevention and control measures were then implemented to reduce the spread of the epidemic. Influenza, another respiratory tract virus...

Full description

Bibliographic Details
Main Authors: Xiangsha Kong, Feng Liu, Haibo Wang, Ruifeng Yang, Dongbo Chen, Xiaoxiao Wang, Fengmin Lu, Huiying Rao, Hongsong Chen
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Journal of Virus Eradication
Subjects:
SARS-CoV-2
COVID-19
Influenza
Prevention
Control measures
China
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664021000133
id doaj-b73361c9a6d7424b8db2e2615c97f646
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Xiangsha Kong
Feng Liu
Haibo Wang
Ruifeng Yang
Dongbo Chen
Xiaoxiao Wang
Fengmin Lu
Huiying Rao
Hongsong Chen
spellingShingle Xiangsha Kong
Feng Liu
Haibo Wang
Ruifeng Yang
Dongbo Chen
Xiaoxiao Wang
Fengmin Lu
Huiying Rao
Hongsong Chen
Prevention and control measures significantly curbed the SARS-CoV-2 and influenza epidemics in China
Journal of Virus Eradication
SARS-CoV-2
COVID-19
Influenza
Prevention
Control measures
China
author_facet Xiangsha Kong
Feng Liu
Haibo Wang
Ruifeng Yang
Dongbo Chen
Xiaoxiao Wang
Fengmin Lu
Huiying Rao
Hongsong Chen
author_sort Xiangsha Kong
title Prevention and control measures significantly curbed the SARS-CoV-2 and influenza epidemics in China
title_short Prevention and control measures significantly curbed the SARS-CoV-2 and influenza epidemics in China
title_full Prevention and control measures significantly curbed the SARS-CoV-2 and influenza epidemics in China
title_fullStr Prevention and control measures significantly curbed the SARS-CoV-2 and influenza epidemics in China
title_full_unstemmed Prevention and control measures significantly curbed the SARS-CoV-2 and influenza epidemics in China
title_sort prevention and control measures significantly curbed the sars-cov-2 and influenza epidemics in china
publisher Elsevier
series Journal of Virus Eradication
issn 2055-6640
publishDate 2021-06-01
description At the end of 2019, an outbreak of pneumonia took place caused by a new coronavirus (SARS-CoV-2 virus), named coronavirus disease 2019 (COVID-19). A series of strict prevention and control measures were then implemented to reduce the spread of the epidemic. Influenza, another respiratory tract virus, may also respond to these measures. To assess the impact of these measures, we used the total number of passengers movement in mainland China from 2018 to 2020 and daily number of railway passenger flow during the 2020 Spring Festival travel rush to reflect the population movement and to analyze newly and cumulatively confirmed COVID-19 and influenza cases. We found that implementing the series of measures against COVID-19 mitigated both COVID-19 and influenza epidemics in China. Prevention and control measures for COVID-19 might be used to control respiratory tract infections to reduce the national health economic burden caused by these pathogens.
topic SARS-CoV-2
COVID-19
Influenza
Prevention
Control measures
China
url http://www.sciencedirect.com/science/article/pii/S2055664021000133
work_keys_str_mv AT xiangshakong preventionandcontrolmeasuressignificantlycurbedthesarscov2andinfluenzaepidemicsinchina
AT fengliu preventionandcontrolmeasuressignificantlycurbedthesarscov2andinfluenzaepidemicsinchina
AT haibowang preventionandcontrolmeasuressignificantlycurbedthesarscov2andinfluenzaepidemicsinchina
AT ruifengyang preventionandcontrolmeasuressignificantlycurbedthesarscov2andinfluenzaepidemicsinchina
AT dongbochen preventionandcontrolmeasuressignificantlycurbedthesarscov2andinfluenzaepidemicsinchina
AT xiaoxiaowang preventionandcontrolmeasuressignificantlycurbedthesarscov2andinfluenzaepidemicsinchina
AT fengminlu preventionandcontrolmeasuressignificantlycurbedthesarscov2andinfluenzaepidemicsinchina
AT huiyingrao preventionandcontrolmeasuressignificantlycurbedthesarscov2andinfluenzaepidemicsinchina
AT hongsongchen preventionandcontrolmeasuressignificantlycurbedthesarscov2andinfluenzaepidemicsinchina
_version_ 1721301914756317184
spelling doaj-b73361c9a6d7424b8db2e2615c97f6462021-07-15T04:27:14ZengElsevierJournal of Virus Eradication2055-66402021-06-0172100040Prevention and control measures significantly curbed the SARS-CoV-2 and influenza epidemics in ChinaXiangsha Kong0Feng Liu1Haibo Wang2Ruifeng Yang3Dongbo Chen4Xiaoxiao Wang5Fengmin Lu6Huiying Rao7Hongsong Chen8Peking University People's Hospital, National Clinical Research Center for Infectious Disease, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International Cooperation Base for Science and Technology on NAFLD Diagnosis, Beijing, ChinaPeking University People's Hospital, National Clinical Research Center for Infectious Disease, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International Cooperation Base for Science and Technology on NAFLD Diagnosis, Beijing, ChinaPeking University Clinical Research Institute, Peking University Health Science Center, Beijing, ChinaPeking University People's Hospital, National Clinical Research Center for Infectious Disease, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International Cooperation Base for Science and Technology on NAFLD Diagnosis, Beijing, ChinaPeking University People's Hospital, National Clinical Research Center for Infectious Disease, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International Cooperation Base for Science and Technology on NAFLD Diagnosis, Beijing, ChinaPeking University People's Hospital, National Clinical Research Center for Infectious Disease, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International Cooperation Base for Science and Technology on NAFLD Diagnosis, Beijing, ChinaPeking University People's Hospital, National Clinical Research Center for Infectious Disease, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International Cooperation Base for Science and Technology on NAFLD Diagnosis, Beijing, China; State Key Laboratory of Natural and Biomimetic Drugs, Department of Microbiology & Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China; Corresponding author. Peking University People's Hospital, National Clinical Research Center for Infectious Disease, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International Cooperation Base for Science and Technology on NAFLD Diagnosis, Beijing, China.Peking University People's Hospital, National Clinical Research Center for Infectious Disease, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International Cooperation Base for Science and Technology on NAFLD Diagnosis, Beijing, China; Corresponding author.Peking University People's Hospital, National Clinical Research Center for Infectious Disease, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International Cooperation Base for Science and Technology on NAFLD Diagnosis, Beijing, China; Corresponding author.At the end of 2019, an outbreak of pneumonia took place caused by a new coronavirus (SARS-CoV-2 virus), named coronavirus disease 2019 (COVID-19). A series of strict prevention and control measures were then implemented to reduce the spread of the epidemic. Influenza, another respiratory tract virus, may also respond to these measures. To assess the impact of these measures, we used the total number of passengers movement in mainland China from 2018 to 2020 and daily number of railway passenger flow during the 2020 Spring Festival travel rush to reflect the population movement and to analyze newly and cumulatively confirmed COVID-19 and influenza cases. We found that implementing the series of measures against COVID-19 mitigated both COVID-19 and influenza epidemics in China. Prevention and control measures for COVID-19 might be used to control respiratory tract infections to reduce the national health economic burden caused by these pathogens.http://www.sciencedirect.com/science/article/pii/S2055664021000133SARS-CoV-2COVID-19InfluenzaPreventionControl measuresChina

Similar Items